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Recent reports emphasizing experimental biochemical changes suggesting
lipoprotein and connective tissue dysmetabolism in familial primary systemic
amyloidosis (1—10) have alerted us to the intriguing concept of possible connec-
tive tissue changes in those dermatopathic states ordinarily not so defined. Urti-
caria pigmentosa has been considered by many to represent an anomaly of the
little understood mast cell-heparin interrelationship. Hoxvever, insufficient atten-
tion has been given to the extra-coagulative mast cell-connective tissue dichot-
omy in its broadest, and perhaps most important aspect. Staemmler (11), in
his excellent monograph on the mast cell, underscored the importance of this
cell in this relationship when he called attention to the challenging possibility
that these structures were in a sense unicellular "glands" \vhose function was
that of producing the necessary mucin for the development of the interfibrillary
cement substance (hyaluronic acid, chondroitin sulfuric acid). Higuchi (12)
indirectly enhanced these observations when he noted that mast cells were
characteristically increased in the presence of connective tissue destruction.
The coexistence of urticaria pigmentosa and primary systemic amyloidosis would
serve to focus attention not only on the secretory capacities of the mast cell
alone, but also upon the immediate and distant effect of these discharges upon
the milieu of the cell itself.
Therefore, we are reporting in detail these coexisting, and possibly related
diseases, in a case studied by us with several objectives in view: to review the
available literature as to the significant clinical, hematologic, hepatic, hemo-
static, and roentgenographic data as relates to urticaria pigmentosa, and to
emphasize where possible those clinical and laboratory features that appear
peculiar to primary systemic amyloidosis. Further, it is intended to summarize
and correlate recent experimental advances in mast cell function in terms not
only of coagulation physiology, but also as representing a cell whose function in
relationship to clinical states extends into the little known areas of histamine
release, heparin-lipemia clearing factors, and lipoprotein metabolism. The con-
cept of heparia-lipid interrelationships and lipoprotcin transport has received
some impetus from the work of Reilly et al. (13) who recently reported their ex-
perimental biochemical experiences with a case of urticaria pigmentosa utilizing
ultracentrifugal analyses of the serum beta lipoproteins, where it was found that,
under cortisone induced artificial conditions, abnormal elevations of the Sc
0—12 and S 20—100 components occurred. Finally, it is the aim of this case re-
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port to speculate upon the possibility that systemic urticaria pigmentosa may
represent not only histamine-heparin abnormalities alone but the joint existence
of these cellular errors coupled with, and perhaps exceeded by, connective tissue
substance derangements (21). Whether this reciprocal set of phenomena repre-
sents mere chance in this case remains to be proven.
Case Report
W.R.F., age 73, farmer, was first seen in the University of Michigan Dermatology Out-
patient Clinic February 5, 1952 complaining of a moderately pruritic eruption over the
chest, abdomen, and extremities of approximately 6 weeks duration. Significant past history
consisted of "rheumatism" which he recently had been treating with slight effect by a pre-
scribed medication. Further inquiry elicited the observation that he had not been well
since November 1952 at which time he noted the gradual onset of easy fatigability, weak-
ness, and "loss of pep". For approximately 2 months he had suffered from a constant "burn-
ing" of the stomach unrelated to meals and not accompanied by anorexia, nausea or vomit-
ing. Weight loss and an episode of non-bloody diarrhea of one month duration completed the
clinical story.
Past history revealed that he had undergone a transurethral prostatectomy for benign
prostatism in December 1944. There was also a history of asthma and hay fever beginning
at approximately 30 years of age, triggered by animal effiuvium and dust, for which he had
undergone repeated desensitization procedures.
The patient was first admitted to the University of Michigan Hospital February 5, 1952
for the diagnosis and treatment of what appeared to be a system disease.
Physical examination: cachexia with evidence of recent weight loss. Temperature, pulse,
and blood pressure were normal. The skin was found to be atrophic, dry, and with little
turgor. A striking, almost universal, maculo-papular, non-grouped, reddish-purple eruption
was noted. Some of the lesions appeared to have a superficial crust and were found to vary in
size from 2—4 mm. The lesions in the abdominal area appeared to have a definite purpuric
nature. There was no evidence of ecchymoses. Firm stroking of the macules and papules
resulted in marked urtication with a halo of erythema about them. Over the shoulders
peculiar, numerous miliary subcutaneous nodules, distinctly related to fascial planes, were
described. There was no evidence of weeping or excoriation.
The ears, nose and throat were normal. The tongue was not enlarged. The neck and im-
mediate structures were grossly within normal limits.
Examination of the chest revealed findings compatible with pulmonary emphysema. A
small, firm, fixed mass, believed to be a lymph node, was found in the left supra-clavicular
area. Similar and larger masses were noted in both axillae. In addition, a firm, egg-shaped,
and non movable mass was located over the third left rib posteriorly. A similar, softer mass
was noted in the left medial scapular area. The cardiovascular survey was non-contribu-
tory.
Abdominal findings revealed the presence of an enlarged, non-tender, non-nodular liver.
The spleen was also enlarged with no unusual features being noted by palpation. There was
no evidence of abdominal tenderness or fluid accumulation. The genitals were normal. The
inguinal lymph nodes were enlarged bilaterally. Neurologic examination revealed a bilateral
decrease in the deep reflexes of the upper and lower extremities. There was a deformity of
the thumb of the right hand with atrophy of the thenar muscle. Otherwise, the remainder
of the physical examination was within normal limits. The clinical impressions were those of
urticaria pigmentosa, lymphoblastoma, carcinomatosis, drug reaction, and gouty arthritis.
Laboratory data: Hb. 10.0 gms. with 2,500,000 red blood cells per cu. m.m., and a hema-
tocrit of 33.5% volumes percent. The white blood count was 5,600 with 38 PMNs, 14 lympho-
cytes, 1 eosinophile, and apparently a normal number of platelets. The striking finding in
the blood smear was the large increase in atypical monocytes (47%). ESR (corrected) was
31 mm. per hour. Urinalysis revealed a trace of albumin. STS was negative. Total serum
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FIG. 1. Biopsy of skin (HE, low power) showing clusters of mast cells beneath the epi-
dermis.
protein 9.2%, albumin 4.47, and globulin 4.8% (A/G ratio 0.9). Serum uric acid was reported
as being elevated (7.8 mgm.%).
Special blood and bone marrow stndies by the Simpson Memorial Institute (Febrnary 8,
1952) revealed the following changes: the blood film findings consisted of 40 PMNs, 6 large
lymphocytes, S small lymphocytes, 3 promonocytes, and 43 vacuolated, toxic monocytes.
The platelets were normal. Sternal marrow aspiration (February 13, 1952) demonstrated a
hypercellular specimen. A relative and absolute decrease in erythropoiesis with an E/L
ratio of 1:12 was described. Numerous mature granulocytes were noted, however, granu-
lopoiesis was characterized by primitive cells of varying size with abundant blue-grey
opaque cytoplasm, aznrophilic and non-specific granules, coarse reticulation of the chruma-
tin, and frequent nucleoli. Differentiation appeared to tend toward large atypical mono-
cytoid progranulocytes, myelocytes, and metamyelocytes. Megakaryocytes were numerous.
These findings were believed to be compatible with a subacute, sublenkemic granulocytic
leukemia (myelo-monocytic type).
Biopsy of the maculopapular skin lesion (HE stain) revealed abnndant focal infiltrations
of mast cells in the papillary and subpapillary layers of the dermis. No amyloid was found.
Giemsa stains of this tissue showed isolated mast cells in the upper dermis.
X-ray studies of the chest demonstrated bilateral pulmonary emphysema. Spine x-ray
changes were those of hypertrophic arthritis, rotoscoliosis, with questionable collapse of
several dorsal vertebrae. The gastro-intestinal series were negative.
The patient's course in the hospital was not remarkable. He complained of weakness, and
fatigue and diminution of appetite. Treatment consisted of 2 blood transfusions and topical
inunctions. He was discharged February 19, 1952 with the diagnoses of urticaria pigmentosa,
sobacute, subleukemic grannlocytic leukemia, and hypertrophic spondylitis.
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From March—June 1952 he was followed in the Outpatient Department. Persistent com-
plaints were those of weakness, anorexia, and "burning" of the stomach. An extreme
pruritus of the upper extremities characterized this period of the disease. A recurrent, brief,
non-bloody diarrhea was likewise described by the patient. Examination revealed the pres-
ence of infiltrated, purplish plaque-like lesions over the arms and right leg. Laboratory data
was compatible with an anemia (fib. 8.5—9.9 gms.), leucopenia (4,150—4,750 white cells), and
a monocytosis (29—47%). Treatment consisted of blood transfusions, vitamins and a high
calory diet.
Second admission (July 14, 195)
Persistent epigastric pain, anorexia, generalized pruritus, recurrent diarrhea, and
vomiting necessitated readmission to the hospital. Pertinent new cutaneous changes con-
sisted of varying-sized colorless nodules (1.0—5.0 cm.) over the ribs, clavicles, sacrum and
hands. Colorless, miliary nodules were interspersed in areas of larger nodulation. These were
non-tender and appeared to be subcutaneous in location.
Laboratory data: hematologic values were essentially unchanged. Urinalysis revealed a
faint trace of albumin with no Bence-Jones protein. NPN was 51 mgm%. Total serum
proteins were unchanged. Electrolytes were normal. X-ray of the chest showed a soft tissne
mass elevating the left scapula and a similar mass in the left lateral wall. A blood film was
repeated and demonstrated no remarkable further changes. The marrow aspirate of Febru-
ary 13, 1952 was reviewed and the coneensus at this time was that the marrow pattern repre-
sented a monoeytic reaction to a chronic disease process. With the information at hand it
was concluded that there was no definite evidence in the peripheral blood or marrow of a
FIG. 2. Lung tissue (HE, high power). The alveolar septum demonstrates a complete
infiltration of this structure with amyloid.
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lymphomatous process. Bone marrow aspiration was repeated August 8, 1952 with the find-
ings being essentially unchanged.
Histopathological examination of a specimen secured from the left infraclavicular area
demonstrated chiefly coarse collagenous tissue with early calcification. Special stains re-
vealed a slight metachromatic reaction compatible with primary systemic amyloidosis.
Microscopic examination of the left inguinal node showed a marked reticulo-endothelial
cell hyperplasia and fibrosis of the sinnses. Amorphous basophilic deposits were observed
in the walls of vessels without metaehromasia. In further pursuit of the possibility of pri-
mary amyloidosis 2 cc. of 1% solution of congo red was injected intradermally in the right
deltoid area. Persistence of the dye in the skin together with a remarkable spread over the
right arm was believed to indicate a positive test for amyloid deposition.
The patient was discharged from the hospital August 8, 1952 with his condition un-
changed. The patient returned to the out-patient clinic infrequently. During this period
there appeared aseites, scrotal, and lower extremity edema. These were somewhat controlled
by sodium restriction diuretics, and paracenteses. In view of these developments and
gelleral progressive deterioration he was again readmitted to the hospital.
Third admission (September 20, 1952)
Persistent, oozing bleeding from the paracenteses site necessitated readmission. Perti-
nent physical findings were those of fluid retention, eeehymoses, and failure of the macnb-
papular lesions to urticate on firm stroking. Hematobogic findings consisted of an anemia,
leukopenia, and monocytosis. The urine contained 3+ albumin. Treatment consisted of re-
peated blood transfusions, vitamin K for his bleeding tendency, sodium restriction, diu-
retics, and paracenteses. He was discharged from the hospital slightly improved Septem-
ber 24, 1952.
Fourth admission (October 7, 1952)
The patient was readmitted at this time because of increasing fluid retention with
respiratory distress, burning and pruritus of the face and scalp, sharp shooting pains in the
lower extremities, repeated epistaxes, and vomiting. Physical examination revealed a chron-
ically ill, emaciated male. Large masses elevated the angles of the scapulae. A large firm
mass was attached to the superior border of the right scapula and similarly along the border
of the clavicle. Moderately sized masses were described beneath the scapulae, posterolateral
neck, and over the elbows. The macubopapular eruption had a large element of purpura.
Large hematomas were present over the right forearm and the left anterior chest wall. In
addition to marked clinical evidence of fluid retention, the liver and spleen were further
increased in size.
Laboratory data: hematologic values were unchanged. A liver profile revealed abnormal
values for eephalin flocculation (4+), prothrombin time (54%), and total serum proteins
(8.6%). Abnormal tests of hemostatic function consisted of a markedly prolonged bleeding
time of 25 minutes, and a depressed prothrombin time (vide supra) with other values being
normal. Electrolyte determinations were within normal limits. A tuberculin skin test was
positive (1:10,000). Intravenous congo red absorption test was negative (31%). An electro-
cardiogram revealed small QRS complexes. Treatment efforts at dehydrating the patient
were partially successful and the patient was discharged from the hospital October 16, 1952.
Fifth (final) admission (February 13, 1953)
Subsequent to the fourth admission the patient deteriorated rapidly with uncontrollable
fluid retention, weakness, severe abdominal pain, and progressive constipation with vomit-
ing. Physical examination revealed clinical evidence of profound fluid retention (chest,
lungs, abdomen, scrotum, and lower extremities). A universal tissue wasting was present.
Discrete, small, firm lymph nodes were palpable in the cervical and axillary areas. Blood
pressure was found to be normal. Hematobogie and urine studies were essentially unchanged.
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NPN was recorded as being 53 mgm%. Total serum protein had decreased to 7.0%. Biopsy
of the right inguinal node revealed microscopic evidence of amyloid material iu the vessel
walls and node fat. Vigorous measures to correct the fluid retention were partially success-
ful. He was discharged somewhat improved March 3, 1953. Shortly thereafter, March 30,
1953, he died at home in his sleep approximately 16 mouths after the onset of his illness.
Autopsy report
The antopsy was done on the day of death and after embalming.
External examination revealed an emaciated elderly male with evidence of universal
muscle atrophy. The axillary and inguinal lymph nodes were discrete, hard, and on section
had a grey, fleshy appearance with a firm consistency. The skin was atrophic. Numerous
small, flat, lightly pigmented macules and papules were present. Some were covered with a
thin scale. Ecehymoses were observed on the right thigh, dorsum of the left foot, left ankle,
and dorsums of the hands. Pitting edema of the ankles, sacrum, and sears of biopsies and
paracenteses were noted.
Examination of the brain and spinal cord were essentially negative.
Examination of the thorax: the right and left pleural cavities contained 500 and 300 cc.
of straw-colored fluid respectively. The heart was not enlarged (220 gms.), with a firm, dark
red-brown myocardium. The coronaries were patent. There was emphysema of the anterior
portion of the lungs with congestion and edema of the lower portions. The thoracic esopha-
gus was uniformly firm, thickened to 3 em. from the eardio-esophageal juncture.
The larynx, trachea and cervical esophagus were not unusual. The tongue was not en-
FIG. 3. Nodal tissue secured at autopsy (HE, high power). Per pheral deposit of masses
of amyloid together with venous infiltration by this material.
yr-'
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Fin. 4. Autopsy specimen of skin (HE, low power) demonstrating clusters of mast cells
below the epidermis with abundant amyloid in the dermis.
larged. The thyroid gland was firm and fibrous revealing a grey color on cut section. The
cervical nodes were small, firm.
Examination of the abdomen: all tissues, especially the viscera were very firm in consist-
ency and paler than usual. This in part appeared to be due to the embalming procedure.
The panniculus was slight and orange-red in color. The muscle appeared a pale red-brown.
The abdominal cavity contained 7000 cc. of clear fluid. The liver (1200 gm.) extended 3 cm.
below the ensiform cartilage and above the level of the right costal margin in the midcln-
vicular line. The spleen was enlarged but did not extend below the left costal margin. It
weighed 480 gms. and was covered by sessile plaques of gray hyalinc material. The cut sur-
face was firm, medium red in color with prominent gray follicles. No definite sago or larda-
ceous appearance was noted. The large intestine was thin and the small intestine had firm
pale walls. The third portion of the duodenum was opened in situ and revealed a constriction
at the first and second portion of this structure. The surrounding tissue n-as firm and rub-
bery giving the impression of neoplasm. The duodenal mucosa was thickened. In the first
portion of the duodenum there were 4 small superficial ulcers, the bases of which were
covered with hemorrhagic exudates. The stomach was essentially negative. The pancreas
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face of the liver was red-brown. The mesentery was grossly normal except for the discrete
small, gray-yellow, hard lymph nodes that were present. The adrenals and kidneys were
grossly normal. The retroperitoneal nodes were numerous, large, hard, discrete which on
section presented a gray-yellow homogeneous appearance. The bladder was small with a
smooth shining mucosa.
Examination of the bones: marked hypertrophic osteoarthritic deformities of the ver-
tebral column and joints of the extremities. The marrow of the vertebral bodies was red-
brown with soft gray-yellow and firm grey areas scattered throughout.
Significant microscopic findings: in the brain, the pituitary body was characterized by
an increased hyalinization between the acini of the pars glandularis. Most of the material
stained red with Van Gieson's stain, with occasional non-staining areas and slight meta-
chromatic reaction.
The myocardium stained a deep red color with Van Gieson's stain. Beneath the endocar-
dium and about several subepicardial vessels there was deposited a homogeneous, slightly
basophilic material.
In the lungs, amyloid-like material was deposited in the connective tissues beneath the
pleura and the septa. Amyloid material was prominent in the bronchial perinodal tissues and
in the walls of the veins.
The thyroid gland contained a moderate amount of basophilic amyloid in the connective
tissue and in the walls of the veins. This material stained yellow with Van Gieson's stain
and faintly with congo red.
The esophagus demonstrated marked hypertrophy of the muscularis, especially the circu-
lar coat. Abundant amyloid was present in the upper third of the submucosa and mus-
cularis. The diaphragm contained moderate amyloid deposits with atrophy of the myo-
fibrils and fibrosis. In the jejunum and duodenum masses and amyloid were present in the
submucosa centering mainly about the veins. The stomach revealed slight amyloid infiltra-
tion of the submucosa.
The spleen showed marked fibrosis and reticulum cell hyperplasia. The follicles were
small and reduced in number. Collections of immature myeloid cells were present, but no
megakaryocytcs. A thickened capsule contained a small amount of amyloid. No amyloid was
found in the pancreas or liver. The adrenals demonstrated slight amyloid deposition in the
capsular veins.
Lymph node (axillary, mescntcric, rctroperitoncal, and pen-pancreatic) involvement
consisted of marked rcticulo-endothelial cell hypcrplasia, hemosiderosis, atrophy of the
follicles, without lcukcmic infiltration. In the tissue about the capsule there was a very
prominent deposition of a homogeneous material which stained basophilic with HE stain,
yellow with Van Gieson's and pink with congo red.
Amyloid was observed in the walls of vessels in the dcrmic and subcutaneous tissues of
the skin. Mast cells were present just beneath the epidermis.
The bone marrow was extremely cellular with myeloid types cells observed with a spar-
sity of megaharyocytes. There was an increased absorption of bone trabcculac and fibrosis
of the marrow about some of the trabeculao. The findings were compatible with diffuse
myclosis with fibrosis.
The seminal vcsicles and bladder revealed amyloid deposition in the walls of veins and
in the surrounding tissues.
Pathological diagnoses: (1) diffuse, non-leukemic myclosis with fibrosis involving the
bone marrow and spleen; (2) atypical amyloidosis of the primary type involving connective
tissues throughout the body and especially the esophagus, duodenum, jcjunum, lymph
nodes, skin, urinary bladder, and thyroid; (3) stenosis of the duodenum at the junction of
the first and second portions; (4) urticaria pigmcntosa; (5) massive ascites, pleural effusion,
peripheral, pulmonary and cerebral edema; (6) splcnomcgaly, hemosiderosis of the spleen,
liver, lymph nodes; (7) subcutaneous ccchymoscs; (8) malnutrition; (9) hypertrophic
arthritis.
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DISCUSSION
As far as can be determined, this case study represents the first documenta-
tion of the co-existence of urticaria pigmentosa and primary systemic amy-
loidosis in a patient proven by tissue biopsy and necropsy. While a precise de-
limitation of the ultimate role of each process in the patient's deterioration and
demise cannot be defined, there are certain documented features of each morbid
state which permit cautious comparative analysis. In this regard, the unusual
historical, clinical, hematological, hemostatic, and necropsy features are worthy
of comment. The information that the patient had suffered from long-standing
hay fever and asthma with attempts at desensitization are in harmony with
some of the clinical details of amyloid deposition (3). The occurrence of profound
weakness, burning or pain in the epigastrium, alternating diarrhea and constipa-
tion, subcutaneous nodules, and remarkable lymphadenopathy have been well
documented in the latter condition (3).
While anemia and a hemorrhagic state have been noted in both diseases, the
presence of leukopenia, monocytosis, and necropsy evidence of diffuse, non-leu-
kemic myelosis and fibrosis of the spleen and bone marrow demonstrate the need
of calling attention to these hitherto unemphasized features of systemic mast
cell disease. When histopathologic evidence is considered, the preponderance of
amyloid material in significant body tissues is emphasized. It would seem that no
matter what the comparison of disease characteristics might indicate, the duality
of insult to connective tissue is apparent and significant.
In view of the increasing evidence that urticaria pigmentosa may manifest
signs, symptoms, and laboratory changes of a systemic nature, a statistical re-
view of the available literature emphasizing these features was felt to be indi-
cated. Fifteen cases of systemic urticaria pigmentosa were available for review
(13—26). Fourteen of these were found in the white and one in the colored race.
Ten were males and 5 were females. The ages ranged from 12 months to 71 years.
Three cases occurred in the first 1z years of life, while 9 were found in the third
through the fifth decades and 2 in the sixth and seventh decades. In one case
report the age of the patient was not recorded.
The history of antecedent, co-existent, complicating, or systemic features was
described in 11 cases. Touraine (14) noted the history of arthritis in his case.
In another (15) abdominal swelling was prominent. A long-standing history of
"nervousness" was reported in Bolgert and LeSorde's (16) patient. The 51 year
old male studied by Degas et al. (18) complained of anorexia, weakness, and chest
pain. In another (21) weight loss and pain and limitation of motion in the joints
was significant. The possible relationship of a gonococcal endocervieitis in the
mother at the birth of the affected child has been commented upon (23). Blue-
farb and Salk (24) emphasized the unusual gastro-intestinal history consisting
of bloating, flatulence, and alternating diarrhea and constipation in a 30 year
old male. Arthritis and diarrhea of 20 years duration together with weakness and
fatigue represented some of the unusual features in the case documented by
Berlin (25). An acute infectious episode complicated the cases described by Reilly
et al. (13) and Gruneberg et al. (26). It is of interest to note that in several of
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these cases that some time during the lifetime of the individual weakness, gastro-
intestinal and skeletal complaints formed the core of the clinical story. These
observations may be significant.
Data on the physical findings were available in all cases. In every report the
skin lesions noted were compatible with the documented expression of urticaria
pigmentosa or its telangiectatic variant (24). Hemorrhagic lesions (purpura,
ecchymoses) were described in the macules, papules, nodules, or normal skin in 5
cases (16, 17, 25, 26). Grayish nodular lesions of the forehead were noted by
Ellis (15). Degas et at. (18) were impressed by the bluish-yellow infiltration of the
skin and an indolent, indurated ulcer of the buttock in their 51 year old male.
Sagher et al. (19) noted the presence of kyphosis, emphysema, and cardiomegaly
in their elderly male patient. In another report (21) an unusual rouge-brown pig-
mentation of the thorax was noted. Degas et al. (23) commented upon the old
ivory coloration of the skin in their 13 month old male. Another report (25)
noted the evidence of fluid retention in the abdomen, genitalia, and lower ex-
tremities. Bullae were noted in 2 cases (23, 26).
Lymph node enlargement (cervical, axillary, inguinal) was found in 2 males,
both in the fifth decade of life (18, 21). Hepatic enlargement, non-tender, non-
nodular, occurred in 5 cases all males (18, 15, 21, 25, 13). A similar number of
cases, all males, were reported to manifest enlarged spleens (14, 18, 24, 25, 13).
It would seem then, that the occurrence of hepatomegaly and/or splenomegaly
in a case of urticaria pigmentosa in a male would be presumptive evidence of
systemic disease in approximately one-third of the cases.
Laboratory findings, where documented in detail, lend themselves in part to
significant statistical analyses. Anemia, varying from mild to moderately severe
was recorded in 8 cases. In no case was data presented suggesting a hemolytic
process as a causative factor in the anemic process. Leucopenia was present in 4
cases (16, 18, 25, 13). A moderate to profound monocytosis (9—47%) was de-
scribed in 6 cases (14, 16, 21, 22, 23, 13). Aihuminuria (trace—1+) was noted in
2 cases. The STS was negative in those patients wherein it was recorded. The
measures of renal function as represented by NPN or BUN were abnormal in 3
cases. X-rays of the skull, chest, spine and long bones were recorded in 8 cases.
In 4 of these there was no evidence of osseous abnormality (15, 18, 23, 25).
Sagher et al. (19) found generalized cystic osteoporosis of the ribs with thickening
of the bone trabeculae compatible with multiple myeloma. In the skull stippling
of bone structures and thickening of the skull tables was noted. A mild sclerosis
was present in the pelvic bones and the lumbar vertebrae. All of the osseous le-
sions were described as occurring in the areas of cutaneous involvement. Clyman
and Rein (20), studying the osseous changes found in this disease, noted calcific
deposits compatible with bone infarcts in the shoulders and femur of a 40 year
old female. Bone changes, without other physical or laboratory data indicative
of a systemic process, were described in another case by these workers and in
3 cases observed by Grupper and Sobel (27). The presence of generalized osteo-
porosis of the ribs, clavicles, and thoraco-lumbar vertebrae was believed to be
compatible with osteoblastic metastases (elevated alkaline phosphatase) or
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myelofibrosis in the thoroughly documented case of Bluefarb and Salk (24).
Reilly et al. (13) observed patchy osteoporosis with pagetoid thickening of the
bony trabeculae in the skull, pelvis, ribs, and humeri.
Tissue studies were reported in all cases (skin 15, lymph nodes 1, liver 4,
spleen 1, and bone marrow 10). In all of the patients the clinical impression of
urticaria pigmentosa was confirmed by microscopic examination of skin tissue
utilizing routine or special stains. In one case (21) the specimen contained not
only abundant mastocytes, but the collagen of the dermis appeared to be largely
degenerated forming masses of intense blue with polychrome blue stain. Grune-
berg et al. (26) found scattered areas of mastocytes together with 11 % monocytes
in the bullous fluid of their case. Biopsy of a lymph node (18) demonstrated
reticular basophilia and no mast cells. In one case (18) microscopic study of
hepatic tissue secured at biopsy revealed a 70 % mastocytosis. Histopathologic
study of the liver by Degas ci al. (21) revealed the portal spaces to be infiltrated
with reticulocytes and lymphocytes. No mastocytes were noted. Special stains
(Masson's trichrome) demonstrated enlargement of Dissi's spaces which con-
tained a collagenous substance which stained blue. In the Ellis (15) case, micro-
scopic examination of the liver tissue secured at necropsy revealed many mast
cells together with portal cirrhosis in this visdus. The pancreas, spleen, and lymph
nodes were similarly infiltrated. In the case investigated by Reilly ci al. (13)
microscopic study of liver tissue revealed not only a mastocytosis but also evi-
dence of change compatible with Laennec's cirrhosis. Bone marrow aspirations
were normal in 6 of 10 cases. In one of these (15) abundant mast cells were demon-
strated at necropsy. In 3 cases the bone marrow content of mast cells was sig-
nificant—six per cent (18), thirty five per cent (25) and a sheet-like mastocytic
deposition (13).
In most cases, study of liver function by means of a liver battery were either
incomplete or absent. Analysis of this fragmentary data seems to indicate no
trend of hepatic insufficiency (vide infra prothrombin time). The serum bili-
rubin was reported in 2 cases and found normal. The cephalin flocculation
and/or zinc sulfate turbidity and thymol turbidity were elevated in 3 cases.
The alkaline phosphatase was abnormal in 2 cases. Serum protein determina-
tions were available in 5 cases and were found to be abnormal in one.
Data available concerning hemostatic function were significant. Bleeding time
was observed to be abnormal iii 3 cases (16, 18, 26). Coagulation time was like-
wise elevated in 3 cases (16, 18, 13). The capillary resistance test (Rumpel-
Leede) was normal in every instance except one (26). Abnormal prothrombin
times were observed in 5 cases (16, 18, 21, 25, 13). Thrombocytopenia was noted
in the case reported by Berlin (25). Fibrinogen levels were normal in the 2 cases
wherein such studies were reported (17, 25). Feeble hyperheparinemia was ob-
served by Degas et al. (18); in the other case where this possibility was considered
there was no evidence of heparin excess (25). The case investigated by GrUne-
berg et at. (26) is noteworthy in that a thorough study of the possible mechanisms
of hemorrhage was undertaken. In his case clot retraction was found to be 48 %,
antithrombin dilution was elevated, and both in vitro and in vivo heparin toler-
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ance tests revealed increased hypocoagulability. Other tests of hemostasis—
prothrombin complex, prothrombin consumption, fibrinalysis, and fibrinelas-
ticity—were normal.
A number of interesting experimental procedures were undertaken in several
of the cases reported. Konrad and Winkler (22), interested in the hemostatic
properties of bullous fluid, found that this material was characterized by strong
anticoagulating effects which were inhibited by the addition of toluidine blue.
The intracutaneous injection of heparin into their patient revealed a remarkable
sensitivity to this substance (allergy). Furthermore, they found that the injec-
tion of this material into an ordinary lesion resulted in the development of a
bulla. Gruneberg et al. (26) injected 100 mgm. of heparin intravenously into their
patient and noted only hypocoagulability of blood without intensification of the
skin lesions. Nor were these workers able to demonstrate any unusual anticoagu-
lating properties of bullous fluid. While they likewise were unable to find hista-
mine in a spontaneous bulla, they were able to show that their patient reacted
strongly to a histamine skin test with a partly hemorrhagic infiltration being
noted 24 hours after injection. Berlin (25) tested his subject to cold application
(ice) for 3 minutes and noted an intense erythema which persisted for several
hours. In this study no mention was made of cryoglobulin determination.
Analysis of the laboratory data suggests several interesting possibilities of
clinical value. In addition to the well known occurrence of anemia in systemic
mast cell disease, it is apparent that more attention should be given to the here-
tofore unemphasized hematological features of leukopenia and especially mono-
cytosis. Thus, another disease process must be added to a long list of chronic
diseases—lues, tuberculosis, typhoid fever, malaria, monocytic leukemia, and
Rocky Mountain spotted fever—wherein an aberration of this cell type may be
significant (28). The significance of osseous changes in systemic urticaria pig-
mentosa is difficult to evaluate. The changes certainly do not appear to be spe-
cific as, at least in part, some of the reported findings are not at all incompatible
with aged normals, multiple myeloma, Von Recklinghausen's disease, and Al-
bright's syndrome. If the significance or insignificance of these changes is to be
entertained, then more cases properly studied from the hematological, hemo-
static, and roentgenologic points of view must be offered in evidence. That skin
biopsy remains the touchstone of diagnosis remains unchallenged. However, the
occurrence of collagenous changes in the dermis in our case and that of Degas
et al. (21) raises a problem. These changes suggest an additional extra-cellular
insult, inherent or co-existent, in systemic heparinocyte disease. The incidence
of bone marrow mastocytosis appears to be low, yet the finding is an important
one. The demonstration of diffuse non-leukemic myelosis with fibrosis involving
the spleen and bone marrow represents the first tissue documentation of this
type of change. Parenthetically, no such changes have been reported in primary
systemic amyloidosis (3). Insofar as the hemostatic function is concerned the
abnormal prothrombin time, bleeding time, and coagulation time represent the
most consistent findings of this facet of the disease. On the other hand, the sig-
nificance of heparin excess in the blood requires further study. Furthermore,
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Continued Careful investigations are needed to determine whether or not these
patients respond abnormally to intravenous heparin injections. The results
secured by the various investigators in the study of anticoagulating or histamine
properties of bullous fluid are at variance. These results do not appear disturb-
ing when it is borne in mind that the mast cell has many unknown capacities
and that thus only one or several secretory or connective tissue influencing func-
tions may he deranged in a subject. The data at hand suggest that on occasion a
heparin abnormality may be preeminent (18, 22, 26), and at another that of
histamine (26, 34). Continuing this line of speculation it is not illogical to con-
ceive a cellular secreting derangement profoundly influencing the homeostasis
of the omnipresent connective tissue milieu.
With recent technical experimental data at hand as relates to mast cell func-
tion, we are now able to place in a hypothetical perspective framework the pos-
sible mechanisms that may be operating in systemic mast cell disease. The ob-
servation by Konrad and Winkler (22) that the heparin effect is preeminent, the
challenge by Gruneberg et at. (26) that histamine might play a predominant role,
and the notation that steroid induced 3-lipoprotein shifts can occur (13) all, in
the light of new investigation, have in common the ultimate role of the mast cell
in disease.
The singular and consistent presence of these cells around capillaries and small
blood vessels without muscular coats thus permitting the discharge of cellular
contents into the connective tissue has been emphasized by several investiga-
tors (29, 11, 30). That these cells tend to migrate from their perivascular location
into adjacent connective tissue has been shown in the rat (30). Holmgren (50)
observed that there is a considerable decrease in mast cells with increasing age.
A species difference in mastocyte development has been emphasized by Page
(31) who stated that in the rabbit, a vulnerable animal in experimental athero-
genetic processes, this cell represents a rudimentary phenomenon, whereas in
the rat the opposite situation prevails (atherogenic resistan ce).
Three rather precise, reasonably documented trends of research interest in
mast cell physiology have become apparent: the demonstration by Jorpes et at.
(32) that heparin is produced by this cell, the finding that this cellular compo-
nent of connective tissue represents a potent, but not only, source of histamine
(30, 33), and the speculation that plasma lipid abnormalities might be related to
the formation of heparin in mast cells or with a complex mechanism controlling
their secretion (51).
The evidence that mast cells contain histamine rests in part on data based on
chemical histamine liberators. Riley (30) injected a lethal intravenous dose of
ultraviolet fluorescent stimulator (stilbamidine) in rats and was able to show
that the perivascular fluorescent spots took up basic dye (mast cells). Riley and
West (33) found that stilbamidine disruption of these cells led to a fall in hista-
mine. That tissue histamine content varied widely was likewise noted by them.
Lung tissue immediately adjacent to the pleura revealed histamine values as high
as 300 mg/gm compared with 100 mg/gm for the lung parenchyma. They also
investigated the effect of intraperitoneal injections of ammonia on the histamine
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content of tissues of rats. Data secured by them seemed to indicate that with the
dimunition of the mast cell population there was a concomitant fall in histamine
levels. West (34) analyzed a nodule rich in mast cells secured from a case of
urticaria pigmentosa and found the phenomenal histamine content of 950 mgm/
gm of tissue. Even higher values were recorded in the dog mast cell tumors and
their metastases.
That the mast cell has an equally important role in the production of heparin
was demonstrated by Jorpes et al. (32, 50). Oliver and co-workers (35) in their
investigation of the heparin content and the specific cytoplasmic content of
neoplast mast cells, found that the heparin content of spontaneous dog mast
cell tumors large in the granule of mature cells and only moderate in those with
immature cells. Phase contrast microscopy demonstrated that in the more
malignant tumor the immature cell appeared to be composed of ill defined grey
particles, while metachromatic dense, and discrete granules were seen in the ma-
ture cells. Analysis of the immature forms disclosed a relatively low content of
heparin (preheparin phase).
While many of the details of the chemistry of heparin are unknown, Jorpes
(36) was able to identify heparin as a mucopolysaccharide resembling the chon-
droitin sulfuric acid of cartilage. The role of heparin in hemostatic processes is
well known (36). Yet, this remarkable substance exerts other profound effects
and is possessed of certain properties: it reduces the isoagglutinin titers of serum,
interferes with enzyme systems, acts on plasma proteins and lipoproteins, and
exerts low osmotic pressure in aqueous solutions. Apparently these multitudinous
capacities may be best explained on the basis of a physico-chemical action of the
acidic polysaceharide on the different proteins concerned.
Recent experimental work by MacIntosh (37) has shown that the basic hista-
mine liberators (clupein sulfate, 48/80, polylysine hydrochloride, toluidine blue)
unite reversibly with heparin in a loose complex. The conditions favoring the
combination with heparin are known for some of the liberators-alkalinity, low
ionic strength, high electric constant, and low temperature of the medium. That
histamine combines with heparin has likewise been observed (37). Gerendas
ci al. (38) noted that histamine opposed the anticoagulant effect of heparin.
That a close relationship existed between heparin and histamine was reported
by Parrot and LaBorde (39) when they discovered that dialysis of a histamine
solution against a heparin solution, the heparin containing component was found
to contain the higher concentration of histamine. Much has been speculated as
to the manner in which histamine and heparin are held within the mast cell.
There is no direct evidence for the concept that histamine is held within the mast
cell by linkages with heparin, nor has it been established that these substances
form part of the same mast cell granule (37). Nevertheless, it is not implausible
to speculate, as does MacIntosh (37) that any basic substance with an affinity
for heparin accumulates in the mast cell where it will form a loose heparin com-
plex without being rendered pharmacologically inert. Julen ci at. (40) propose the
hypothesis that heparin is located on the outer surface of the mast cell granule
and that an exposure of basic liberators at that site might favor lysis with hista-
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mine release. The complex problem of histamine release appears to be related to
several possible mechanisms: (1) a liberator displaces the histamine from its
combination with heparin. (2) That histamine release can be accomplished by
physical disruption of the surface membranes. This latter presumption has
received experimental strength from the work of Hagen (41) and Garcia-Arocha
et at. (42). Another possibility assumes that histamine is reversibly bound by
polar or Van der Walls forces to some component—e.g. a protein or a lipoprotein
—whose molecular weight has been altered by slight treatment with the resultant
loss of its affinity for histamine (37). What happens to heparin when histamine
release is accomplished is unknown. MacIntosh (37) found that histamine rich
liver particles, under certain experimental conditions, contained a metachro-
matically active substance which was probably heparia. However, this sub-
stance did not appear to move with histamine when the medium was rendered
hypotonic.
The complexity of the problem is increased many fold when one focuses atten-
tion upon the role of heparin in lipid transport. That the artificially induced
lipoprotein abnormalities reported by Reilly et at. (13) in their case of urticaria
pigmentosa might represent a facet of this problem justifies speculation. Hahn
(43) showed that hepariri has a profound capacity for removing chylomicrons
from the blood. Experimental data secured by Korns (44) concerning the nature
of heparin action has demonstrated the presence of a tissue enzyme (lipoprotein
lipase) in extracts of acetone powder of normal heart tissue. Further, he found
that the acetone extracts were further activated by the addition of small amounts
of heparin. These findings suggested that clearance of plasma subsequent to
heparin injection might have been due to activation and release of the apo-
enzyme portion of the tissue "lipoprotein lipase." That other factors (albumin,
coprotein) might be necessary for the functioning of this system has been sug-
gested (51). Evidence seems to indicate that heparin is a component prosthetic
group of clearing factors (45, 46, 49). Ultracentrifugal analyses (47) and paper
electrophoretic studies (48) have demonstrated a marked fall in $-lipoprotein
components concomitant with an increase in the a-lipoprotein fraction after the
intravenous injection of heparin. Whether this occurs as the result of an actual
transfer of intact lipid molecules from one compartment to another remains to
be demonstrated (51). Generally, on the basis of sound experimental data, it
appears that the clearing factor system is responsible for the normal levels of
lipoprotein fractions in plasma. Anfinsen (51) in a review of this problem, dis-
cusses the possibility that plasma lipid abnormalities might be related to the
formation of heparin in mast cells or with a mechanism controlling their secre-
tions. These speculations on lipid transport have profound implications that
extend beyond the bounds of urticaria pigmentosa and eater the unlimited do-
main of atherogenesis. That systemic urticaria pigmeatosa might represent the
proper human substrate for the study of the problem of atherosclerosis is indeed
challenging.
What can one conclude concerning this plethora of experimenta data as re-
lates to the mast cell and its functions? First, it would seem that this ubiquitous
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cell represents an important component of connective tissue. Second, it implies
that urticaria pigmentosa without systemic expression might \vell represent a
cellular disorder of synthesis or release of heparinoid or histaminoid substances,
and that conversely the systemic maaifestations of the disease might mirror the
impact of mast cell secretory abnormalities on the homeostasis of the connective
tissue environment. Third, it connotes that this cell, in terms of lipid transport,
might possibly qualify as the "master cell" of the atherogenic process.
SUMMARY
1. Clinical, hematologic, hemostatic, roentgenologic, and necropsy data have
been presented in co-existent systemic urticaria pigmentosa and primary sys-
temic amyloidosis in a 73 year old male. Efforts have been directed toward
clarifying the roles of mast cell disease and amyloid deposition in the patient's
demise.
2. Fifteen cases of systemic urticaria pigmentosa have been reviewed. Sig-
nificant clinical, laboratory and experimental features have been described.
The presence of leukopenia and/or monocytosis have been emphasized as fur-
ther hematological aids in diagnosis.
3. A brief review of mast cell anatomy and physiology has been presented
based on recent experimental data. Based in part on these findings and based on
speculation in the light of these observation a pathophysiologic distinction has
been attempted in terms of the nonsystemic versus the systemic disease. Much
more careful clinical, laboratory, and experimental work must be done to deter-
mine the basic abnormalities of systemic mast cell disease.
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